Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study Article Early Access

Industry Collaboration International Collaboration

cited authors

  • Garon, Edward B.; Winfree, Katherine B.; Molife, Cliff; Cui, Zhanglin Lin; Arriola, Edurne; Levy, Benjamin; Mekhail, Tarek; Perol, Maurice

authors

Publication Date

  • April 21, 2020

webpage

published in

category

keywords

  • Aggressive disease
  • Docetaxel
  • Healthcare resource utilization
  • Non-small-cell lung cancer
  • Ramucirumab